Donor Gamma-Glutamyl Transferase Is Associated With Liver Allograft Discard and Failure

Theodore Zhang1, Brian Hickner1, Ronald Cotton2

  • 1School of Medicine, 3989Baylor College of Medicine, Houston, TX, USA.

Progress in Transplantation (Aliso Viejo, Calif.)
|March 17, 2021
PubMed

Insights

Donor Gamma-Glutamyl Transferase (GGT) levels impact liver transplant outcomes. High GGT increases discard risk, while low GGT may protect against graft failure, optimizing donor liver utilization.

Area of Science:

  • Hepatology
  • Transplant Surgery
  • Biochemistry

Background:

  • Liver transplantation faces a critical shortage of donor organs.
  • Maximizing the utility of available liver allografts is essential.
  • Predicting graft failure is crucial for patient and resource management.

Purpose of the Study:

  • To investigate the association between donor Gamma-Glutamyl Transferase (GGT) levels and liver allograft discard.
  • To determine the relationship between donor GGT and post-transplant graft failure.

Main Methods:

  • Multivariate analysis of 53,966 deceased liver donors.
  • Adjustment for donor clinical and demographic factors.
  • Analysis of graft failure data from 47,269 liver recipients.

Main Results:

  • Donor GGT significantly correlates with allograft discard, particularly levels >200 U/L (OR 2.74).
  • Donor GGT <20 U/L demonstrates a protective effect against graft failure (HR 0.91).
  • GGT is an independent predictor of liver discard and graft failure.

Conclusions:

  • Donor GGT levels should be integrated into allograft discard assessment during organ procurement.
  • Understanding GGT's role can improve donor liver selection and transplant success.
  • Further research into GGT's mechanistic role in graft survival is warranted.
Abstract

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
141
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
692
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
138